Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Investigational New Drugs|January 1, 1985
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study)J D Cowan, C K Osborne, J A Neidhart, et al.
Cancer Research|July 1, 1992
Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitorK B Reddy, G L Mangold, A K Tandon, et al.
Journal of the National Cancer Institute|March 10, 1999
Statistical analysis of array expression data as applied to the problem of tamoxifen resistanceS G Hilsenbeck, W E Friedrichs, R Schiff, et al.
Science (New York, N.Y.)|September 23, 1983
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancyK J Ibbotson, S M D'Souza, K W Ng, et al.
British Journal of Cancer|February 24, 2001
High rates of loss of heterozygosity on chromosome 19p13 in human breast cancerS Oesterreich, D C Allredl, S K Mohsin, et al.
Cancer Research|January 4, 1998
Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancerG M Clark, D C Allred, S G Hilsenbeck, et al.
The Journal of Biological Chemistry|April 10, 1999
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damageS Li, P L Chen, T Subramanian, et al.
Molecular Endocrinology (Baltimore, Md.)|May 13, 1999
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivoA V Lee, J G Jackson, J L Gooch, et al.
The Journal of Clinical Investigation|November 1, 1989
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic miceC L Arteaga, L J Kitten, E B Coronado, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group studyC K Osborne, B Blumenstein, E D Crawford, et al.
Pageof 24